Cargando…

Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution

Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to...

Descripción completa

Detalles Bibliográficos
Autores principales: La Rosa, Ruggero, Johansen, Helle Krogh, Molin, Søren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944626/
https://www.ncbi.nlm.nih.gov/pubmed/35326882
http://dx.doi.org/10.3390/antibiotics11030419
_version_ 1784673762197635072
author La Rosa, Ruggero
Johansen, Helle Krogh
Molin, Søren
author_facet La Rosa, Ruggero
Johansen, Helle Krogh
Molin, Søren
author_sort La Rosa, Ruggero
collection PubMed
description Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to diagnose and characterize. Due to our lifestyle, persistent infections caused by opportunistic bacteria—well-known or emerging—show increasing success of infecting patients with reduced defense capacity, and often antibiotics fail to be sufficiently effective, even if the bacteria are susceptible, leaving small bacterial populations unaffected by treatment in the patient. The mechanisms behind infection persistence are multiple, and therefore very difficult to diagnose in the laboratory and to treat. In contrast to antibiotic resistance associated with acute infections caused by traditional bacterial pathogens, genetic markers associated with many persistent infections are imprecise and mostly without diagnostic value. In the absence of effective eradication strategies, there is a significant risk that persistent infections may eventually become highly resistant to antibiotic treatment due to the accumulation of genomic mutations, which will transform colonization into persistence.
format Online
Article
Text
id pubmed-8944626
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89446262022-03-25 Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution La Rosa, Ruggero Johansen, Helle Krogh Molin, Søren Antibiotics (Basel) Opinion Antibiotic resistance is expected by the WHO to be the biggest threat to human health before 2050. In this overview, we argue that this prediction may in fact be too optimistic because it is often overlooked that many bacterial infections frequently ‘go under the radar’ because they are difficult to diagnose and characterize. Due to our lifestyle, persistent infections caused by opportunistic bacteria—well-known or emerging—show increasing success of infecting patients with reduced defense capacity, and often antibiotics fail to be sufficiently effective, even if the bacteria are susceptible, leaving small bacterial populations unaffected by treatment in the patient. The mechanisms behind infection persistence are multiple, and therefore very difficult to diagnose in the laboratory and to treat. In contrast to antibiotic resistance associated with acute infections caused by traditional bacterial pathogens, genetic markers associated with many persistent infections are imprecise and mostly without diagnostic value. In the absence of effective eradication strategies, there is a significant risk that persistent infections may eventually become highly resistant to antibiotic treatment due to the accumulation of genomic mutations, which will transform colonization into persistence. MDPI 2022-03-21 /pmc/articles/PMC8944626/ /pubmed/35326882 http://dx.doi.org/10.3390/antibiotics11030419 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
La Rosa, Ruggero
Johansen, Helle Krogh
Molin, Søren
Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title_full Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title_fullStr Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title_full_unstemmed Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title_short Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution
title_sort persistent bacterial infections, antibiotic treatment failure, and microbial adaptive evolution
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944626/
https://www.ncbi.nlm.nih.gov/pubmed/35326882
http://dx.doi.org/10.3390/antibiotics11030419
work_keys_str_mv AT larosaruggero persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution
AT johansenhellekrogh persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution
AT molinsøren persistentbacterialinfectionsantibiotictreatmentfailureandmicrobialadaptiveevolution